Status: current, Defined. Date: 30-Nov 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3028411000168118 | Serenace (haloperidol 20 mg / 2 mL) injection, 10 x 2 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3028421000168113 | Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | Is a | haloperidol 20 mg/2 mL injection, 10 x 2 mL ampoules | true | Inferred relationship | Some | ||
| Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | has TPUU | Serenace 20 mg/2 mL injection, 2 mL ampoule | true | Inferred relationship | Some | 1 | |
| Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | has TP | Serenace | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | Is a | True | Serenace 20 mg/2 mL injection, 10 x 2 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR